Prexa Pharmaceuticals

Prexa Pharmaceuticals

Verified
Prexa Pharmaceuticals develops small molecule monoamine reuptake inhibitors as a treatment for ADHD, depression and Parkinson’s disease
  • Edit
DateInvestorsAmountRound
$7mSeries B
Total Funding$7m

Recent News about Prexa Pharmaceuticals

Edit